7 Days Left! Connexion Shenzhen 2025 Opens in One Week with Expanded Sectors, 2500+ Exhibitors and Industry-Defining Events A premier gateway for product sourcing across the Greater Bay Area SHENZHEN,…CISION PRNewswireDecember 9, 2025
Press ReleaseZuttoNyan Relaunches: Science-Driven, Companionship-Led — Redefining a New Standard for Pet Living TOKYO, Dec. 9, 2025 /PRNewswire/ — In Japan’s rapidly growing 2025 pet…CISION PRNewswireDecember 9, 2025
CGTN: In the wake of tragedy, Hong Kong comes together to rebuild BEIJING, Dec. 9, 2025 /PRNewswire/ — CGTN published an article on the…CISION PRNewswireDecember 9, 2025
Press ReleaseUrban Traffic Pollution: A Hidden Risk in Malaysia's Growing Cities KUALA LUMPUR, Malaysia, Dec. 9, 2025 /PRNewswire/ — Malaysia’s economy is growing, with…CISION PRNewswireDecember 9, 2025
Press ReleaseSingaporeans Are Living in Smaller Homes — But at What Cost to Health? SINGAPORE, Dec. 9, 2025 /PRNewswire/ — As Singapore’s homes become increasingly compact,…CISION PRNewswireDecember 9, 2025
Press ReleaseRockwell Automation Asia Pacific Earns 2025 Great Place To Work Certification™ SINGAPORE, Dec. 9, 2025 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s…CISION PRNewswireDecember 9, 2025
Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine HONG KONG, Dec. 9, 2025 /PRNewswire/ — From November 23 to 25,…CISION PRNewswireDecember 9, 2025
Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ — Innovent Biologics,…CISION PRNewswireDecember 9, 2025